Overview
CERT market data
Price History
CERT price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.01 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.44 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -16.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.45 – $13.88 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.2B · P/B 1.32 · P/S 3.01.
Company News
8-K filing — Certara, Inc. (CERT)SEC EDGAR · Aug 7, 2026, 8:20 PM
Barclays Maintains Equal-Weight on Certara, Raises Price Target to $7.5Benzinga · Aug 5, 2026, 11:05 AM
Transcript: Certara Q2 2026 Earnings Conference CallBenzinga · Aug 4, 2026, 1:42 PM
Certara shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY26 guidance below estimates.Benzinga · Aug 4, 2026, 12:39 PM
Certara Lowers FY2026 Adj EPS Guidance from $0.35-$0.41 to $0.31-$0.36 vs $0.38 Est; Lowers FY2026 Sales Guidance from $395.000M-$405.000M to $367.000M-$382.000M vs $398.585M EstBenzinga · Aug 4, 2026, 11:07 AM
Certara Q2 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $93.271M Miss $98.392M EstimateBenzinga · Aug 4, 2026, 11:06 AM
Certara, Silo Pharma Advance AI Agent Strategies with Nvidia InitiativesBenzinga · Jul 7, 2026, 6:25 PM
Certara Partners With NVIDIA To Advance Its Open Integrated AI Platform, Unifying Scientific Software, Regulatory Expertise, And Proprietary Datasets With AI-First, Agentic FrameworksBenzinga · Jul 7, 2026, 12:10 PM
Franklin Covey Cuts Revenue Forecast, Joins Ouster And Other Big Stocks Moving Lower In Thursday’s Pre-Market SessionBenzinga · Jul 2, 2026, 12:05 PM
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the FirmGlobenewswire Inc · Jun 19, 2026, 7:15 PM